177 related articles for article (PubMed ID: 37649158)
1. Effect of 2-methoxyestradiol treatment on early- and late-stage breast cancer progression in a mouse model.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cell Biochem Funct; 2023 Oct; 41(7):898-911. PubMed ID: 37649158
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2-methoxyestradiol on mammary tumor initiation and progression.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2068. PubMed ID: 38600057
[TBL] [Abstract][Full Text] [Related]
3. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice.
Ottewell PD; Brown HK; Jones M; Rogers TL; Cross SS; Brown NJ; Coleman RE; Holen I
Breast Cancer Res Treat; 2012 Jun; 133(2):523-36. PubMed ID: 21956211
[TBL] [Abstract][Full Text] [Related]
6. STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.
Meyer-Losic F; Newman SP; Day JM; Reed MJ; Kasprzyk PG; Purohit A; Foster PA
PLoS One; 2013; 8(12):e80305. PubMed ID: 24324595
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
[TBL] [Abstract][Full Text] [Related]
9. Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice.
Zagozdzon AM; O'Leary P; Callanan JJ; Crown J; Gallagher WM; Zagozdzon R
BMC Cancer; 2012 May; 12():209. PubMed ID: 22646761
[TBL] [Abstract][Full Text] [Related]
10. The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
Shishido SN; Delahaye A; Beck A; Nguyen TA
Int J Cancer; 2014 Mar; 134(6):1474-83. PubMed ID: 24038078
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
12. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
[TBL] [Abstract][Full Text] [Related]
14. The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma.
Du B; Wang SY; Shi XF; Zhang CF; Zhang ZZ
Tumori; 2011; 97(5):660-5. PubMed ID: 22158500
[TBL] [Abstract][Full Text] [Related]
15. Deletion of
MartÃnez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
16. Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia.
Kalliomäki TM; McCallum G; Wells PG; Hill RP
Cancer Lett; 2009 Sep; 282(1):98-108. PubMed ID: 19356843
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
19. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
Huh JI; Calvo A; Charles R; Green JE
Cancer Res; 2006 Apr; 66(7):3495-503. PubMed ID: 16585173
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
